Nucleus Medisurge Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.98 Cr
- Satisfied Charges ₹ 1.50 Cr
- Revenue Growth -35.53%
- Profit Growth -68.90%
- Ebitda -29.20%
- Net Worth 12.75%
- Total Assets 48.56%
About Nucleus Medisurge
Nucleus Medisurge Private Limited (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 March 2015 (Nine years and 11 months 13 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.98 Cr. The company has closed loans amounting to ₹1.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Shinde and Prashant Gomkale serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24233PN2015PTC154240
-
Company No.
154240
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Mar 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nucleus Medisurge?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Shinde
|
Director | 04-Mar-2015 | Current |
|
Prashant Gomkale
|
Director | 04-Mar-2015 | Current |
Financial Performance of Nucleus Medisurge.
Nucleus Medisurge Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.53% decrease. The company also saw a substantial fall in profitability, with a 68.9% decrease in profit. The company's net worth Soared by an impressive increase of 12.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nucleus Medisurge?
In 2023, Nucleus Medisurge had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nucmed Pharma LlpPallavi Shinde and Prashant Gomkale are mutual person
-
Herkules Pharmaceuticals Private Limited
Prashant Gomkale is a mutual person
-
Eastin Diagnostics Private Limited
Prashant Gomkale is a mutual person
Charges (Loans)
₹39.80 M
₹15.00 M
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 3.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2023 | Yes Bank Limited | ₹3.98 Cr | Open |
| 05 Jan 2023 | Others | ₹1.50 Cr | Satisfied |
How Many Employees Work at Nucleus Medisurge?
Unlock and access historical data on people associated with Nucleus Medisurge, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleus Medisurge, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Medisurge's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
